Keyphrases
Acute Myeloid Leukemia
91%
Pediatric Leukemia
78%
Childhood Acute Lymphoblastic Leukemia
74%
Acute Lymphoblastic Leukemia
65%
Dutch
39%
Diffuse Intrinsic Pontine Glioma
37%
Pediatric
36%
Children with Cancer
33%
Drug Resistance
32%
Childhood Cancer
27%
Relapsed or Refractory Acute Myeloid Leukemia
25%
Chemotherapy
25%
Childhood Cancer Survivors
23%
Pediatric Acute Lymphoblastic Leukemia
21%
Prednisolone
20%
Pediatric Oncology
18%
Methotrexate
17%
L-asparaginase
17%
Childhood Leukemia
17%
Cytarabine
17%
Overall Survival
16%
Quality of Life
16%
Healthcare Professionals
16%
Kenya
16%
Bortezomib
16%
Leukemia Patients
16%
Event-free Survival
16%
Indonesia
16%
Leukemia
16%
Tumor
15%
In Vitro Resistance
15%
Childhood Cancer Treatment
15%
Working Diagnosis
15%
Oncology
15%
Pediatric Patients
14%
Ara-C
14%
Survivors
14%
Treatment Outcome
14%
Protease Inhibitors
12%
Childhood Cancer Patients
12%
MTT Assay
12%
Cancer Treatment
12%
Health-related Quality of Life
12%
Daunorubicin
11%
Vincristine-induced Peripheral Neuropathy
11%
Healthcare Provider Perspectives
11%
Newly Diagnosed
11%
Prognostic Significance
11%
Doxorubicin
10%
Folate
10%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Childhood Cancer
73%
Acute Lymphoblastic Leukemia
66%
Pediatric Acute Myeloid Leukemia
57%
Pediatrics
55%
Malignant Neoplasm
41%
Chemotherapy
37%
In Vitro
25%
Pontine Glioma
23%
Disease
23%
Overall Survival
21%
Drug Resistance
21%
Leukemia
19%
Cancer Therapy
19%
Neoplasm
18%
Event Free Survival
17%
Acute Myelogenous Leukemia
16%
Quality of Life
14%
Adolescence
14%
Leukemia Cell
13%
Cytarabine
12%
Health Care Provider
12%
Acute Leukemia
12%
Vincristine
11%
Proteasome Inhibitor
11%
Pediatrics Patient
11%
Radiation Therapy
11%
Oncology
11%
Bortezomib
10%
Systematic Review
10%
Diagnosis
9%
Clinical Trial
9%
Survival Rate
9%
Liposomal Daunorubicin
9%
Randomized Controlled Trial
8%
Ganglioneuroblastoma
8%
Minimal Residual Disease
8%
Prednisolone
8%
Childhood Leukemia
8%
Prognostic Factor
8%
Retrospective Study
8%
Methotrexate
7%
Proteasome
7%
Wilms' Tumor
7%
Cytotoxicity
7%
Gene Expression
7%
Cancer
7%
High Risk Population
7%
Complementary and Alternative Medicine
7%
Neuropathy
7%